SUMMARY A simple, sensitive enzyme linked fluorescence immunoassay has been developed to detect IgM antibodies against Chlamydia trachomatis. Reticulate bodies and elementary bodies from C trachomatis L/434 Bu strain were isolated and used as antigens in the assay. Of 113 serum samples obtained from infants with pneumonia, 27 (23.9%) had IgM antibodies to C trachomatis L2 reticulate bodies and nine (8.0%) had IgM antibodies to C trachomatis L2 elementary bodies (titre , 1/500). Specific IgM antibodies were not detected in 20 control serum samples obtained from healthy adults and children. The possible use of enzyme linked fluorescence assay to determine IgM antibodies in the serodiagnosis of C trachomatis infection is discussed.
Chlamydia trachomatis causes a wide range of infections in adults and children, including trachoma, infantile pneumonia, neonatal inclusion conjunctivitis, non-gonococcal urethritis and other diseases of the eye and genital tract. C trachomatis infection may be shown either by isolating the organisms in tissue culture or less often by serological means; in infantile pneumonia it is usual to make the diagnosis serologically.' In a previous study we isolated C trachomatis from infants with pneumonia and detected IgM antibodies to C trachomatis by the indirect immunofluorescence test. 23 Up to now the most reliable technique for the serodiagnosis of C trachomatis infection has been the microimmunofluorescence test of Wang and elementary body ELFA showed that the infants with pneumonia had higher fluorescence unit values than the other groups examined (Fig. 6 Serological tests are not particularly useful in the diagnosis of C trachomatis infections except in patients experiencing their first episode of the disease. The chronic nature of C trachomatis infections makes rising antibody titres a very unlikely finding.' 22 IgM antibodies to C trachomatis are most likely to be detected in cases of systemic chlamydial infection, especially infantile pneumonia. The present results have shown the ELFA to be sensitive and able to determine accurately IgM antibodies against C trachomatis from infants with pneumonia.
